Author
Listed:
- Wendy Balemans
(Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium. akoul@its.jnj.com)
- Nacer Lounis
(Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium. akoul@its.jnj.com)
- Ron Gilissen
(Pharmaceutical Research and Development, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium)
- Jerome Guillemont
(Centre de Recherche Janssen-Cilag, Johnson & Johnson, Campus de Maigremont BP615, F-27106 Val de Reuil cedex, France)
- Kenny Simmen
(Tibotec BVBA, Johnson & Johnson, Gen. De Wittelaan L 11B 3, B-2800 Mechelen, Belgium)
- Koen Andries
(Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium. akoul@its.jnj.com)
- Anil Koul
(Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium. akoul@its.jnj.com)
Abstract
Arising from: S. Brinster et al. Nature 458, 83–86 (2009)10.1038/nature07772 ; Brinster et al. reply Recently, Brinster et al.1 suggested that type II fatty-acid biosynthesis (FASII) is not a suitable antibacterial target for Gram-positive pathogens because they use fatty acids directly from host serum rather than de novo synthesis. Their findings, if confirmed, are relevant for further scientific and financial investments in the development of new drugs targeting FASII. We present here in vitro and in vivo data demonstrating that their observations do not hold for Staphylococcus aureus, a major Gram-positive pathogen causing several human infections. The observed differences among Gram-positive pathogens in FASII reflects heterogeneity either in fatty-acid synthesis or in the capacity for fatty-acid uptake from the environment.
Suggested Citation
Wendy Balemans & Nacer Lounis & Ron Gilissen & Jerome Guillemont & Kenny Simmen & Koen Andries & Anil Koul, 2010.
"Essentiality of FASII pathway for Staphylococcus aureus,"
Nature, Nature, vol. 463(7279), pages 3-3, January.
Handle:
RePEc:nat:nature:v:463:y:2010:i:7279:d:10.1038_nature08667
DOI: 10.1038/nature08667
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:463:y:2010:i:7279:d:10.1038_nature08667. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.